2018年
Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design
Contemporary Clinical Trials
- 巻
- 69
- 号
- 開始ページ
- 40
- 終了ページ
- 47
- 記述言語
- 英語
- 掲載種別
- DOI
- 10.1016/j.cct.2018.04.002
- リンク情報
-
- DOI
- https://doi.org/10.1016/j.cct.2018.04.002
- J-GLOBAL
- https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201802232444716511
- PubMed
- https://www.ncbi.nlm.nih.gov/pubmed/29627620
- Web of Science
- https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000435054600005&DestApp=WOS_CPL
- ID情報
-
- DOI : 10.1016/j.cct.2018.04.002
- ISSN : 1551-7144
- eISSN : 1559-2030
- J-Global ID : 201802232444716511
- PubMed ID : 29627620
- Web of Science ID : WOS:000435054600005